The invention relates to methods of preventing or inhibiting the onset and/or treating autoimmune demyelinating neuropathy and other autoimmune or inflammatory diseases involving macrophage infiltration.
INHIBITOR OF MACROPHAGE SCAVENGER RECEPTOR 1 (MSR1) FOR THE TREATMENT OF AUTOIMMUNE DEMYELINATING DISEASES